ATP/IL‐33‐triggered hyperactivation of mast cells results in an amplified production of pro‐inflammatory cytokines and eicosanoids

Paul M. Jordan,Nico Andreas,Marco Groth,Philine Wegner,Franziska Weber,Ute Jäger,Claudia Küchler,Oliver Werz,Edgar Serfling,Thomas Kamradt,Anne Dudeck,Sebastian Drube
DOI: https://doi.org/10.1111/imm.13386
2021-06-30
Immunology
Abstract:IL-33 and ATP are alarmines which are released upon damage of cellular barriers or are actively secreted upon cell stress. Due to high density expression of the IL-33 receptor T1/ST2 (IL-33R), and the ATP receptor P2X7, mast cells (MCs) are one of the first highly sensitive sentinels recognizing released IL-33 or ATP in damaged peripheral tissues. Whereas IL-33 induces the MyD88-dependent activation of the TAK1-IKK2-NF-κB signaling, ATP induces the Ca2+-dependent activation of NFAT. Thereby each signal alone only induces a moderate production of pro-inflammatory cytokines and lipid mediators (LMs). However, MCs which simultaneously sense (co-sensing) IL-33 and ATP display an enhanced and prolonged activation of the TAK1-IKK2-NF-κB signaling pathway. This resulted in a massive production of pro-inflammatory cytokines such as IL-2, IL-4, IL-6 and GM-CSF as well as of arachidonic acid-derived cyclooxygenase (COX)-mediated pro-inflammatory prostaglandins (PGs) and thromboxanes (TXs), hallmarks of strong MC activation. Collectively, these data show that co-sensing of ATP and IL-33 results in hyperactivation of MCs which resembles to MC activation induced by IgE-mediated crosslinking of the FcεRI. Therefore, the IL-33/IL-33R and/ or the ATP/P2X7 signaling axis are attractive targets for therapeutical intervention of diseases associated to the loss of integrity of cellular barriers such as allergic and infectious respiratory reactions.
immunology
What problem does this paper attempt to address?